Ocular surface lubrication and stabilization (null)

"Ocular surface lubrication and stabilization" is not a single molecular target but rather describes a physiological process essential for maintaining eye health. The **ocular surface** relies on a stable **tear film**, composed primarily of lipid, aqueous, and mucin layers, which together provide critical **lubrication** to minimize friction during blinking and protect against epithelial damage. Disruption in this system leads to conditions such as dry eye disease. Therapeutic strategies focus on supplementing or stabilizing these layers using agents like hyaluronan, poly(vinylpyrrolidone), perfluorohexyloctane (F6H8), or drugs that stimulate mucin secretion such as diquafosol sodium. These interventions aim to restore tear film stability by enhancing its lubricating properties or reducing evaporation from the ocular surface.[1][2][3][4]\n\nThis entry is not a canonical molecular target but rather an umbrella term describing multiple mechanisms involving various molecules—primarily glycoproteins like mucins—and physical processes that maintain ocular comfort and health.[4]

Other names

Ocular surface lubricationTear film stabilizationLubrication of ocular surfaceTear film maintenance

Enhancement or stabilization of the tear film to reduce evaporation and friction[2][3][4]; Promotion of mucin secretion to improve lubrication[3]; Formation or supplementation of a protective fluid layer on the ocular surface[1][2]